Sri Sai Biopharmaceutical Solutions
Biotechnology, 320 Montevue Ln, Frederick, Maryland, 21702, United States, 11-50 Employees
Who is SRISAI BIOPHARMACEUTICAL SOLUTIONS
SriSai Biopharmaceutical Solutions (SBS) has been providing comprehensive support services to the life sciences industry for over 15 years in the areas of supply chain management. These s...
Read More
-
Headquarters: 320 Montevue Ln, Frederick, Maryland, 21702, United States
-
Date Founded: 2002
-
Employees: 11-50
-
Revenue: $10 Million to $25 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 7389
Does something look wrong? Fix it. | View contact records from SRISAI BIOPHARMACEUTICAL SOLUTIONS
SriSai Biopharmaceutical Solutions Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding SriSai Biopharmaceutical Solutions
Answer: SriSai Biopharmaceutical Solutions's headquarters are located at 320 Montevue Ln, Frederick, Maryland, 21702, United States
Answer: SriSai Biopharmaceutical Solutions's official website is https://srisaibiopharma.com
Answer: SriSai Biopharmaceutical Solutions's revenue is $10 Million to $25 Million
Answer: SriSai Biopharmaceutical Solutions's SIC: 7389
Answer: SriSai Biopharmaceutical Solutions has 11-50 employees
Answer: SriSai Biopharmaceutical Solutions is in Biotechnology
Answer: SriSai Biopharmaceutical Solutions contact info: Phone number: Website: https://srisaibiopharma.com
Answer: SriSai Biopharmaceutical Solutions (SBS) has been providing comprehensive support services to the life sciences industry for over 15 years in the areas of supply chain management. These services include storage and global distribution, secondary packaging and labeling, validation and consultation. SBS currently serves clients from both the government and commercial sectors with adherence to Good Laboratory Practices (GLP), Good Manufacturing Practices (GMP), Good Clinical Practices (GCP), Good Documentation Practices (GDP), Food and Drugs Administration (FDA) administration regulations and in accordance with client requirements. These activities are in support of Phase I, and/or II, and/or III clinical studies (Investigational New Drug also known as IND or New Drug Application also known as NDA).
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month